Digre KB
Ophthalmology Department, John A. Moran Eye Center, University of Utah Health Sciences Center, 50 North Medical Drive, Salt Lake City, UT 84132, USA.
Curr Treat Options Neurol. 1999 Mar;1(1):74-81. doi: 10.1007/s11940-999-0035-3.
A thorough assessment of vision with special attention to formal visual field testing is the cornerstone to decision making in idiopathic intracranial hypertension. After the diagnosis of idiopathic intracranial hypertension has been established, vision should be thoroughly assessed. If there is no visual loss, the patient can be followed carefully. In patients with symptoms and only a few signs (eg, mild blind-spot enlargement), acetazolamide, 1 to 2 g, or another diuretic should be initiated. In patients with progressive visual loss in whom maximal diuretic therapy fails and in those who on initial evaluation have significant recent visual loss that does not respond to maximal diuretic therapy, optic nerve sheath decompression or lumbar peritoneal shunting should be carried out. With all treatments, weight loss should be encouraged. All patients should be evaluated regularly with visual field testing.
对视力进行全面评估,尤其要重视正规的视野检查,这是特发性颅内高压决策制定的基石。在确诊特发性颅内高压后,应全面评估视力。如果没有视力丧失,可以对患者进行密切随访。对于有症状且仅有一些体征(如轻度盲点扩大)的患者,应开始使用1至2克乙酰唑胺或其他利尿剂。对于视力进行性丧失且最大剂量利尿剂治疗无效的患者,以及初始评估时有近期明显视力丧失且对最大剂量利尿剂治疗无反应的患者,应进行视神经鞘减压或腰大池腹腔分流术。在所有治疗过程中,都应鼓励患者减重。所有患者都应定期进行视野检查评估。